Startseite Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests

  • Michael Safinowski , Birgit Wilhelm , Tanja Reimer , Alexander Weise , Nicole Thomé , Heike Hänel , Thomas Forst und Andreas Pfützner
Veröffentlicht/Copyright: 2. März 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: In the course of type 2 diabetes mellitus, insulin resistance has a severe impact on endothelial function leading to decreased synthesis of nitric oxide (NO). Postprandial hyperglycemia leads to the generation of reactive oxygen species, which counteracts the beneficial NO effects. NO and superoxide combine very fast in solution to form peroxynitrite, which is a potent protein-oxidizing agent. The peroxynitrite concentrations can be indirectly monitored by the detection of nitrotyrosine residues in proteins, reflecting the extent of damage caused by oxidative stress.

Methods: Four commercially available nitrotyrosine-specific immunoassays were evaluated by parallel measurement of nitrotyrosine in 224 serum samples derived from 16 patients with type 2 diabetes and 12 healthy controls (13 male and 15 female, age: 33±11 years) following a standardized meal.

Results: The available ELISA tests were not applicable for nitrotyrosine determination in human plasma samples due to technical issues and implausible results. However, a competitive luminescence assay was able to provide sufficient sensitivity and lead to clinically meaningful results in our test samples.

Conclusions: All three ELISA methods were disqualified and conclusions previously derived from clinical experiments using these tests should be carefully reconsidered or reconfirmed. In the absence of a liquid tandem chromatography-mass spectrometry reference method, the luminescence test appears to be the method of choice for determination of nitrotyrosine in human plasma.

Clin Chem Lab Med 2009;47:483–8.


Corresponding author: Prof. Dr. Dr. Andreas Pfützner, IKFE GmbH, Parcusstr. 8, 55116 Mainz, Germany Phone: +49-6131-576-3613, Fax: +49-6131-576-3611,

Received: 2008-10-20
Accepted: 2009-1-05
Published Online: 2009-03-02
Published in Print: 2009-04-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Minireview
  2. Risk loci for type 2 diabetes – Quo vadis?
  3. Genetics and Molecular Diagnostics
  4. A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies
  5. Genotype distribution of estrogen receptor α polymorphisms in pregnant women from healthy and preeclampsia populations and its relation to blood pressure levels
  6. Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?
  7. The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis
  8. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma
  9. Expression of lineage markers using real-time quantitative polymerase chain reaction (RT-qPCR) in normal and in leukemia bone marrow
  10. Translation termination and protein folding pathway genes are not correlated in gastric cancer
  11. General Clincial Chemistry and Laboratory Medicine
  12. Novel serum paraoxonase activity assays are associated with coronary artery disease
  13. Elevated erythrocyte carbonic anhydrase activity is a novel clinical marker in hyperventilation syndrome
  14. Elevation of the glycoxidation product Nε-(carboxymethyl)lysine in patients presenting with acute myocardial infarction
  15. Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer
  16. A high-performance liquid chromatography method for the determination of carbamazepine and carbamazepine-10,11-epoxide and its comparison with chemiluminescent immunoassay
  17. Reference Values and Biological Variations
  18. Minimizing the effects of multicollinearity in the polynomial regression of age relationships and sex differences in serum levels of pregnenolone sulfate in healthy subjects
  19. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
  20. Validation and Outcome Studies
  21. Analytical precision of the Urolizer® for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI
  22. Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests
  23. Estimation of trueness of measurement results obtained in external quality assessment
  24. Letters to the Editor
  25. A new PCR-RFLP assay for –1123 G>C polymorphism in the PTPN22 gene: allele and genotype frequencies in a western Mexican population
  26. Proposed classification of various limit values (guide values) used in assisting the interpretation of quantitative laboratory test results
  27. Case report: Over-substitution of thyroxine due to interference in serum thyroid-stimulating hormone measurement
  28. Rv2629 191A/C nucleotide change is not associated with rifampicin resistance in Mycobacterium tuberculosis
Heruntergeladen am 5.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.095/html
Button zum nach oben scrollen